p***@gmail.com
2017-01-26 20:12:21 UTC
Classic, classic switch campaign
Today I bought some BMY because of its low price and news of its cancer drug versus Merck's cancer drug.
Portfolio of PAF on 26JAN2017
VZ 1,700
T 24,630
GSK 730
BMY 100
_______________
27,160
total share-wealth-units last reported which was 20DEC2016 was 27,160 and total share-wealth-units today 27,160
real-estate land 3APR03 of 1 lot $16,500.
real-estate land Sept05 another lot $75,000.
Today, I sold 100 shares of VZ at 49.01 and with the proceeds bought 100 shares of BMY 47.01 per share.
The sell-off in BMY is far too large a sell-off. The application of Opdivo is far better than the Merck Keytruda application. If my memory serves correctly, Opdivo is administered by mouth while Keytruda is injected. But, do not hold me to that. Anyway, if true, most people like pill by mouth.
So this is a classic switch campaign, of wait for BMY to rise above either MRK or VZ.
And in the case of GSK, wait till it rises above T.
AP
Today I bought some BMY because of its low price and news of its cancer drug versus Merck's cancer drug.
Portfolio of PAF on 26JAN2017
VZ 1,700
T 24,630
GSK 730
BMY 100
_______________
27,160
total share-wealth-units last reported which was 20DEC2016 was 27,160 and total share-wealth-units today 27,160
real-estate land 3APR03 of 1 lot $16,500.
real-estate land Sept05 another lot $75,000.
Today, I sold 100 shares of VZ at 49.01 and with the proceeds bought 100 shares of BMY 47.01 per share.
The sell-off in BMY is far too large a sell-off. The application of Opdivo is far better than the Merck Keytruda application. If my memory serves correctly, Opdivo is administered by mouth while Keytruda is injected. But, do not hold me to that. Anyway, if true, most people like pill by mouth.
So this is a classic switch campaign, of wait for BMY to rise above either MRK or VZ.
And in the case of GSK, wait till it rises above T.
AP